[33] [34] In 2026, the UK Medicines and Healthcare products Regulatory Agency (MHRA) updated its guidance on GLP-1 medication after an increase in reports to the agency's Yellow Card Scheme of acute pancreatitis, with fatalities, in patients taking semaglutide or tirzepatide, to warn of a small risk of developing severe acute pancreatitis
On Monday, a pharmaceutical company ended a direct sale deal offering Wegovy at a discount through the Hims & Hers telehealth company
In addition to intestinal mobility, it has become evident that peripheral serotonin participates in systemic energy homeostasis (10, 12)
All existing prior authorizations for weight-loss treatments will be canceled, though coverage for GLP-1 medications prescribed for Type 2 diabetes will continue
You can receive personalized peptide therapy at Optimal Health Medical in Stamford, Connecticut
Kidney Int 67 , 23302337 (2005)